Chemical formula: Li Molecular mass: 6.941 g/mol PubChem compound: 28486
Little is known about the way the lithium ion can modify neurotransmission within the CNS. Many of the proposed mechanisms have suggested an inhibitory effect on components of various neurotransmitter signalling pathways, such as cyclic AMP formation, cyclic GMP formation, G-proteins or inositol phosphate metabolism.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
ATC code | Group title | Classification |
---|---|---|
D11AX04 | Lithium succinate | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals |
N05AN01 | Lithium | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AN Lithium |
V04CX11 | V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CX Other diagnostic agents | |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Title | Information Source | Document Type | |
---|---|---|---|
LI-LIQUID Solution for oral administration | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Lithium is an active ingredient of these brands:
United States (US)
Austria (AT)
Canada (CA)Finland (FI)
France (FR)
Hong Kong (HK)
Israel (IL)
Japan (JP)
Lithuania (LT)
Malta (MT)
Mexico (MX)
Singapore (SG)
South Africa (ZA)Spain (ES)
Tunisia (TN)
Turkey (TR)
United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.